AzTrials
AzTrials

Rouvière's SulcusNCT05912894

Anatomical Variation in Rouvière's Sulcus

An observational study of Rouvière's Sulcus, run by University Of Perugia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Rouvière's sulcus is a 2-5 cm fissure lying on the lower face of the liver, between the right lobe and caudate process. Due to its extrabiliary location, Rouvière's Sulcus could be used as an anatomical landmark for safe laparoscopic cholecystectomy. Read more about this study

Who is it for?
Any age
Conditions the study is for
Rouvière's Sulcus
What is being tested?
Videolaparoscopic cholecystectomy
Type of treatment
Surgery or procedure
How many people
1,000 participants
Where
No sites listed yet
Study dates
1 Sep 2024to 31 Aug 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Laparoscopic cholecystectomy

Who may be able to join

  • Patients undergoing videolaparoscopic cholecystectomy

Who cannot join

  • If the lower face of the right hepatic lobe and the main elements of the biliary tract cannot be clearly analyzed patients will be excluded.

About this study

Official title: Anatomical Variation in Rouvière's Sulcus: a Cross-sectional Study

Rouvière's sulcus is a 2-5 cm fissure lying on the lower face of the liver, between the right lobe and caudate process. Due to its extrabiliary location, Rouvière's Sulcus could be used as an anatomical landmark for safe laparoscopic cholecystectomy. In literature there's an high variability about Rouvière Sulcus prevalence and its anatomical variants.

Read the detailed description

The goal of this observational study is to evaluate the presence of Rouvière Sulcus in patients underwent laparoscopic cholecystectomy. The main questions it aims to answer are the prevalence and the anatomical variations of Rouvière's Sulcus and the variants of Rouvière's Sulcus which are catheghorized according to Singh and Prasad criteria.

The following were considered secondary outcome: operative time expressed in minutes, biliary tract injuries according to Stewart's classification and Vascular injuries.

Being tested
Videolaparoscopic cholecystectomy
Keywords
Prevalence Rouvière's Sulcus, Anatomical variations Rouvière's Sulcus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Videolaparoscopic cholecystectomyProcedure or surgery

    Evaluation of Rouvière's Sulcus Anatomical Variation.

Study groups in NCT05912894
Study groupRoleWhat they receive
Videolaparoscopic cholecystectomyPatients undergoing Videolaparoscopic cholecystectomy
Receives: Procedure: Videolaparoscopic cholecystectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of Rouvière's Sulcus

    Measured: 2 years

  2. Anatomical variations in Rouvière's Sulcus

    The variants of the Rouvière's Sulcus are catheghorized by the classification of Singh e Prasad.

    Measured: 2 years

Secondary outcomes (3)
  1. Operative time

    Time expressed in minutes

    Measured: 2 years

  2. Biliary tract injuries

    Biliary tract injuries according to Stewart's classification.

    Measured: 2 years

  3. Vascular injuries

    Vascular injuries.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2023
  2. Study start1 Sep 2024 (estimated)
  3. Primary completion31 Aug 2025 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05912894
Sponsor's protocol ID
AVRS1
Status last verified
Jul 2024
First submitted
10 Jun 2023
Last updated
5 Jul 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Singh M, Prasad N. The anatomy of Rouviere's sulcus as seen during laparoscopic cholecystectomy: A proposed classification. J Minim Access Surg. 2017 Apr-Jun;13(2):89-95. doi: 10.4103/0972-9941.201731.

    PubMed 28281470
  • Stewart L. Iatrogenic biliary injuries: identification, classification, and management. Surg Clin North Am. 2014 Apr;94(2):297-310. doi: 10.1016/j.suc.2014.01.008.

    PubMed 24679422
  • Pesce A, Fabbri N, Feo CV. Vascular injury during laparoscopic cholecystectomy: An often-overlooked complication. World J Gastrointest Surg. 2023 Mar 27;15(3):338-345. doi: 10.4240/wjgs.v15.i3.338.

    PubMed 37032796

Questions about this trial

What is this clinical trial studying?

An observational study of Rouvière's Sulcus, run by University Of Perugia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of Rouvière's Sulcus (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05912894, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in